INVO Fertility, Inc. Common Stock earnings per share and revenue
On Nov 17, 2025, IVF reported earnings of -0.77 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -1805.94% surprise. Revenue reached 1.76 million, compared to an expected 1.83 million, with a -3.99% difference. The market reacted with a -5.07% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 1.90 million USD, implying an decrease of -93.51% EPS, and increase of 8.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were INVO Fertility, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, INVO Fertility, Inc. Common Stock reported EPS of -$0.77, missing estimates by -1805.94%, and revenue of $1.76M, -3.99% below expectations.
How did the market react to INVO Fertility, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -5.07%, changed from $3.86 before the earnings release to $3.66 the day after.
When is INVO Fertility, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for INVO Fertility, Inc. Common Stock's next earnings report?
Based on 2
analysts, INVO Fertility, Inc. Common Stock is expected to report EPS of -$0.05 and revenue of $1.90M for Q4 2025.